Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by GoldenHawkon Jun 22, 2018 9:18am
79 Views
Post# 28211597

RE:RE:Yesterdays News

RE:RE:Yesterdays News Its a good thing to have partners like this! Will close today with a new high. A lot of great things in the works here. Dollar days are coming! 



MountainMaster wrote: From the ICO website -  iCo Therapeutics is currently engaged in partnership arrangements with MedImmune (a division of Astra Zeneca)Immune Pharmaceuticals and the University of British Columbia.

Medimmune was bought out Astra Zeneca in 2007 for $15.2 Billion dollars. Astra Zeneca ( AZN ) now trades at $35.15 a share. 

Immune Pharmaceuticals  ( IMNP ) had a nice year high of $3.43

Things are looking really good here. 

https://www.icotherapeutics.com/alliances_and_global_licensing/









MountainMaster wrote:

About iCo Therapeutics Inc.

iCo Therapeutics identifies existing development-stage assets for use in underserved ocular and infectious diseases. Such assets may exhibit utility in non-ophthalmic conditions outside the company's core focus areas, and, if so, the company will seek to capture further value through partnerships, such as its partnership with Immune Pharmaceuticals, which is in several phase 2 studies involving iCo-008.


IMNP / Immune Pharmaceuticals had a nice year high of $3.43

ICO could easily follow especially with pending news/results on the way. Just an observation but it looks like ICO is going to go a lot higher. 


 




<< Previous
Bullboard Posts
Next >>